Evaluation of Celecoxib Effects on Amlodipine in Subjects With Existing Hypertension Requiring Antihypertensives

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 105 participants.

Also called NCT02979197

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 105 participants (enrolled count) (from the registry)
Sponsor
Kitov Pharma Ltd (from the registry)
Registry
  • NCT NCT02979197
  • EudraCT 2016-002214-47
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02979197. Randomized; triple masking; primary purpose treatment. Start 2016-11-03 (actual); primary completion 2017-07-21 (actual). Results posted on 2019-10-21.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of Celecoxib Effects on Amlodipine in Subjects With Existing Hypertension Requiring Antihypertensives
Condition
Hypertension
Intervention (Drug)
OE 10 mg amlodipine besylate tablet
Intervention (Drug)
OE 200 mg celecoxib capsule
Intervention (Drug)
Matched placebo for OE amlodipine besylate tablet
Intervention (Drug)
Matched placebo for OE celecoxib capsule
Lead sponsor
Kitov Pharma Ltd (class: not stated)

Record details

Record id
cardio:ct-nct02979197
Content hash
c348d9044a857305d78c91bdc3276284f8d51bfac0f2d7da9762a26bd6d0b50f